@article{04b24b222e4b46478e2cae12d7dcc201,
title = "Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01",
abstract = "Systemic peripheral T-cell lymphomas (PTCLs) respond poorly to conventional therapy. To evaluate the efficacy of a dose-dense approach consolidated by up-front high-dose chemotherapy (HDT) and autologous stem-cell transplantation (ASCT) in PTCL, the Nordic Lymphoma Group (NLG) conducted a large prospective phase II study in untreated systemic PTCL. This is the final report, with a 5-year median follow-up, of the NLG-T-01 study.",
keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Cyclophosphamide, Disease Progression, Disease-Free Survival, Doxorubicin, Etoposide, Europe, Female, Humans, Kaplan-Meier Estimate, Lymphoma, T-Cell, Peripheral, Male, Middle Aged, Multivariate Analysis, Neoadjuvant Therapy, Prednisone, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Stem Cell Transplantation, Time Factors, Transplantation, Autologous, Treatment Outcome, Vincristine, Young Adult",
author = "Francesco d'Amore and Thomas Relander and Lauritzsen, {Grete F} and Esa Jantunen and Hans Hagberg and Harald Anderson and Harald Holte and Anders {\"O}sterborg and Mats Merup and Peter Brown and Outi Kuittinen and Martin Erlanson and Bj{\o}rn {\O}stenstad and Unn-Merete Fagerli and Gadeberg, {Ole Vestergaard} and Christer Sundstr{\"o}m and Jan Delabie and Elisabeth Ralfkiaer and Martine Vornanen and Helle Toldbod",
year = "2012",
doi = "10.1200/JCO.2011.40.2719",
language = "English",
volume = "30",
pages = "3093--9",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "25",
}